Skip to content

iNOVA4Health - Advancing Precision Medicine

Menu
Banner
  • About Us
    • Mission
    • Collaborations
    • Partners
    • Management Board
    • Scientific Advisory Board
    • Careers
    • Contacts
    • Partners
  • Infrastructure
    • BioPilot Plant
    • GMP Analytical Services
    • GenIbet
    • NOVA-CRU
  • Thematic Lines
    • TL1: Neurological and Vision Disorders
    • TL2: Cardio-Metabolic Disorders
    • TL3: Cancer
  • Research Groups
    • RG 1: Cell Bioprocesses for Advanced Therapies
    • RG 2: Molecular Biomarkers and Diagnosis
    • RG 3: Process Engineering for Biopharmaceuticals
    • RG 4: Protein Structure and Function in Biomedicine
    • RG 5: Health Function of Natural Bioactive Molecules
    • RG 6: Retinal Ageing and Disease
    • RG 7: Neuro-Inflammation
    • RG 8: Stroke and Neuroprotection
    • RG 9: Neurophysiology and Degeneration
    • RG10: Cardio-Vascular Diseases
    • RG11: Reno-Vascular Diseases
    • RG12: Diobesity
    • RG13: Musculoskeletal Immune-Regulation
    • RG14: Cell Metabolism and Cancer
    • RG15: Hepatobiliary and Pancreatic Cancer
    • RG16: Familial and Individual Cancer Risk
    • RG17: From Tumour Biology to Cancer Therapies
  • Highlights
  • Intranet

Search form

Partners

  • iBET logo
  • ITQB logo
  • CEDOC logo
  • NOVA Medical School logo
  • IPO logo

News

  • OPEN APPLICATIONS: 8 PhD POSITIONS IN TRANSLATIONAL MEDICINE

    24/02/2022

    Applications are now open for 8 Doctoral Research Grants in the field of Translational Medicine within  iNOVA4Health Research Unit. 

  • OPEN POSITIONS @ CEDOC - NOVA Medical School

    22/02/2022

    Four research groups at CEDOC - NOVA Medical School are looking for PhD applicants for the FCT 2022 call curently open.

  • CaixaResearch Validate and Consolidate Funding Calls 2022

    17/01/2022

    "la Caixa" Foundation offers two funding calls (early-stage and mature projects) to support the transfer of research results to society and the market.

Events

  • LS4FUTURE 1st General Meeting

    08 Feb 23

    LS4FUTURE 1st General Meeting - REGISTRATIONS NOW OPENPlease find attached the preliminary Program for our event and registration link.Registrations close by January 31st.

  • iNOVA4Health Seminar

    07 Feb 23

    Isabelle Bekeredjian-Ding, Head of Microbiology Division, Paul-Ehrlich-Institut, Germany

  • Webinar: Funding opportunities in Cancer Research 2023/2024

    07 Feb 23

    Promotors: AICIB, SGMS, ACSS. Special guest: HaDEA

Publications

  • Target therapy for BRAF mutated anaplastic thyroid cancer: a clinical and molecular study

    2023 / Nunes da Silva T, Rodrigues R, Saramago A, Pires C, Rito M, Horta M, Martins C, Leite V, Cavaco BM

    "significant real-world efficacy of Dabrafenib plus Trametinib in both survival and recurrence compared with standard treatment, with a good safety profile"

    more info

  • Skin-on-a-Chip Technology: Microengineering Physiologically Relevant In Vitro Skin Models

    2022 / Patrícia Zoio and Abel Oliva

    more info

  • Bioactivity and miRNome Profiling of Native Extracellular Vesicles in Human Induced Pluripotent Stem Cell-Cardiomyocyte Differentiation

    2022 / AF Louro, MA Paiva, MR Oliveira, KA Kasper, PM Alves, P Gomes-Alves and M Serra

    more info

© Copyright 2023 iNOVA4HEALTH